
Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket
On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants
Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit
Warrants can be exercised at a price of $5.83 per share, after stockholder approval
Maxim Group LLC is acting as the sole agent for the offering
RSLS fell ~71% in 2024